The brief said, “position basaglar as a starter insulin”. Legal said we can’t say starter, as it implies lesser of a dose. I coined the phrase “beginsulin” and Lilly trademarked it a few weeks later. The sticky phrase beginsulin helped basaglar.com become a huge success, both in traffic and positive responses from patients and HCPs alike.